That the Parliament recognises that October 2025 is Liver Cancer Awareness Month, with cholangiocarcinoma (CCA), which is also known as bile duct cancer, considered to be the second most common primary liver cancer in the world; acknowledges that CCA has few symptoms in its early stages and that people who present with it tend to have quite vague symptoms, such as nausea and loss of appetite, which makes it difficult to diagnose and often managed too late, leading to it having among the worst survival rates of any cancer; notes with concern that, although most cases occur in people over 60, prevalence of the condition appears to be increasing across all age groups, including younger people; notes calls for a comprehensive genomic testing programme, which was approved by NHS Scotland in 2023, to be implemented; believes that this could identify over four-in-five potentially treatable gene faults in CCA patients; welcomes groups such as AMMF, the UK’s only charity solely dedicated to CCA, on providing information and support to people who need it, campaigning to raise awareness and funding research, and notes the view that more needs to be done to raise awareness of this type of cancer to improve outcomes for patients.